Amyris & Genome Compiler Partner to Commercialize DNA Construction Software Services for the Pharma and Biotech Industries

Amyris, Inc. (AMRS), an industrial bioscience company, and Genome Compiler Corp., a synthetic biology platform company, have entered into a collaboration agreement to integrate Amyris’s automated lab services with Genome Compiler’s online design tools and e-commerce platform to enable users to design and order DNA or other biological products seamlessly.